ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1346

Early Diagnosis of Rheumatoid Arthritis: Role of Joint Ultrasound Assessment

Cristina Corrales Selaya1, Carmen Secada Gómez2, Sabela Fernandez-Aguado3, Isla Morante-bolado4, Montserrat Santos-gomez5, Sara Alonso-Castro6, Virginia Portilla-González7, Ricardo Blanco-Alonso8, Javier Rueda Gotor4 and alfonso Corrales-Martínez9, 1Rheumatology, Marques de Valdecilla University Hospital. IDIVAL, Santander, Cantabria, Spain, 2Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain, 3Hospital Universitario Montecelo, Pontevedra, Galicia, Spain, 4Hospital Sierrallana, Torrelavega, Cantabria, Spain, 5Hospital universitario Central de Asturias, Oviedo, Asturias, Spain, 6Hospital Universitario Central de Asturias., Oviedo, Asturias, Spain, 7Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain, 8Division of Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Immunopathology group, Santander, Spain, 9Hospital Universitario Marques de Valdecilla, Santander, Spain

Meeting: ACR Convergence 2024

Keywords: Diagnostic criteria, Erosions, rheumatoid arthritis, Synovitis, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: RA – Diagnosis, Manifestations, & Outcomes Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Early diagnosis of Rheumatoid Arthritis (RA) is essential to establish treatment to improve long-term disease outcomes. Musculoskeletal ultrasound (US) is able to detect subclinical synovitis and erosions earlier than simple radiological study. In recent years, several reduced joint US assessment models have been developed to allow global evaluation of synovitis and joint erosions. The main objective is to evaluate the diagnostic ability of a reduced joint US assessment model in patients with clinically suspected RA.

Methods: Descriptive cross-sectional study including 203 consecutive patients referred to a US care unit for suspected RA, yet not meeting the EULAR/ACR 2010 RA Classification Criteria. Patients were classified into six groups: a) Seropositive (SP) (RF and/or ACPA positive) mono-oligoarthritis, b) SP inflammatory arthralgias c) Nonspecific SP arthralgias, d) Seronegative (SN) (RF and ACPA negative) arthralgias, e) SN Inflammatory Arthralgia,  f) SN nonspecific arthralgias. Each patient underwent a reduced standardized US count to evaluate synovitis in 20 joints (bilateral wrists, 1st-5th metacarpophalangeal (MCPs), and 2nd-5th metatarsophalangeal (MTPs)) and a simplified US count of erosions in 10 joints (bilateral wrists, 2nd and 5th MCPs, 2nd hands proximal interphalangeal (PIP), and 5th MTP). B-mode synovial hypertrophy (SH) and synovial Power Doppler (PD) signal were scored from 0-3 at each joint of the hands, while only the synovial PD signal was scored in metatarsophalangeal joints. Scores ≥ 1 in both B-mode or PD were considered synovitis. The definitive diagnosis was based on the number of inflamed joints detected by physical examination and new joints where synovitis was identified on US.

Results: The study included 203 patients, with 80% women and an average age of 54 ± 13 years. Demographic, clinical features, and laboratory tests are summarized in Table 1. RA was diagnosed in 85 patients (42%). The subgroups with the highest RA diagnosis rates were SP arthritis (93.8%), SP inflammatory arthralgias (76.9%), SN arthritis (40.3%), and SP nonspecific arthralgias (29.4%). Only 15.2% and 5.6% of patients were diagnosed with RA in the SN inflammatory arthralgias and SN nonspecific arthralgias groups, respectively.Undifferentiated arthritis was diagnosed in 57 patients (28.1%), primarily from SN groups: SN arthritis (n=31) and SN inflammatory arthralgias (n=21). Other diagnoses included nonspecific arthralgias and osteoarthritis. No patients had erosions on simple radiological study, but US detected erosions in 36 patients (18%), aiding early diagnosis and indicating a poor long-term functional prognosis. In the SP arthritis group (mainly 1 or 2 joint arthritis), 94% were finally diagnosed with RA, with only one remaining undifferentiated. In contrast, the SN arthritis group (1-9 joints) saw only 40% RA diagnosis, with 46% remaining undifferentiated, highlighting the difficulty in diagnosing RA in SN patients.

Conclusion: Reduced US joint assessment effectively aids in early RA diagnosis and treatment, improving prognosis. The efficacy depends on the clinical scenario prior to the US study.

Supporting image 1

Table 1. Demographic, clinical features, laboratory tests and final ultrasound diagnosis of 203 patients.


Disclosures: C. Corrales Selaya: None; C. Secada Gómez: None; S. Fernandez-Aguado: None; I. Morante-bolado: None; M. Santos-gomez: None; S. Alonso-Castro: None; V. Portilla-González: None; R. Blanco-Alonso: AbbVie, 2, 5, 6, Bristol-Myers Squibb, 2, 6, Galapagos, 6, Janssen, 2, 6, Lilly, 2, 6, MSD, 2, 5, 6, Pfizer, 2, 6, Roche, 2, 5, 6; J. Rueda Gotor: None; a. Corrales-Martínez: None.

To cite this abstract in AMA style:

Corrales Selaya C, Secada Gómez C, Fernandez-Aguado S, Morante-bolado I, Santos-gomez M, Alonso-Castro S, Portilla-González V, Blanco-Alonso R, Rueda Gotor J, Corrales-Martínez a. Early Diagnosis of Rheumatoid Arthritis: Role of Joint Ultrasound Assessment [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/early-diagnosis-of-rheumatoid-arthritis-role-of-joint-ultrasound-assessment/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/early-diagnosis-of-rheumatoid-arthritis-role-of-joint-ultrasound-assessment/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology